Portola Pharma (PTLA) Announces FDA Approval of PAS for Commercial Launch of its Novel Oral Anticoagulant Bevyxxa
Tweet Send to a Friend
Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
